<DOC>
	<DOCNO>NCT00244452</DOCNO>
	<brief_summary>Identify effective dos cetrorelix SR treatment symptom endometriosis , describe dose effect relationship duration symptom relief</brief_summary>
	<brief_title>A Multinational , Randomized , Double-Blind , Placeboâ€‘Controlled , Parallel Group Study Investigate Efficacy , Safety Duration Effect Single Administration Various Doses Cetrorelix SR Subjects With Histologically Confirmed Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>Premenopausal female , history regular menstrual period , symptom dysmenorrhea , dyspareunia pelvic pain assess moderate severe , endometriosis confirm histology within 36 month , use barrier contraception throughout study Insufficient wash period endometriosis treatment , resection destruction endometriotic lesion less 12 week prior screen , need strong opioid analgesic , need immediate surgical treatment endometriosis , condition interferes adherence study procedure study assessment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>Cetrorelix</keyword>
	<keyword>Hormone</keyword>
	<keyword>Symptoms relief</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>